At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Basal Bolus Versus Basal Insulin Regimen for the Treatment of Hospitalized Patients With Type 2 Diabetes Mellitus
In Brief
A Phase 4 clinical trial evaluating sliding scale regular insulin (SSRI), Basal Bolus, and 1 other intervention for Type 2 Diabetes and Hyperglycemia. Completed, enrolled 375 participants across 5 sites.
Detailed Summary
The study is a prospective randomized study comparing safety and effectiveness of a basal-bolus regimen with glargine once daily and glulisine before meals, a basal plus regimen with glargine once daily and supplemental doses of glulisine, and sliding scale regular insulin (SSI) on correction of insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes.
Study Details
Timeline
Interventions
four-time daily in patients with T2DM admitted to general medicine and surgery wards.
glargine once daily plus glulisine before meals (plus corrective doses of glulisine as needed)
glargine once daily plus corrective doses of glulisine before meals and bedtime as needed